{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:18:37Z","timestamp":1720311517494},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,6]]},"DOI":"10.7759\/cureus.63936","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T07:18:20Z","timestamp":1720250300000},"source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous Left Atrial Appendage Closure in a Patient With Acquired Von Willebrand Disease and Atrial Fibrillation"],"prefix":"10.7759","author":[{"given":"Alessandro","family":"Giaj Levra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulrays","family":"Jamie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavia","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go AS","year":"2018","unstructured":"Go AS, Reynolds K, Yang J, et al.. Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study. JAMA Cardiol. 2018, 3:601-8. 10.1001\/jamacardio.2018.1176","journal-title":"JAMA Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne RA","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al.. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023, 44:3720-826. 10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik P","year":"2022","unstructured":"Osmancik P, Herman D, Neuzil P, et al.. 4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022, 79:1-14. 10.1016\/j.jacc.2021.10.023","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12481","article-title":"Acquired von Willebrand syndrome in monoclonal gammopathy - A scoping review on hemostatic management","volume":"5","author":"Abou-Ismail MY","year":"2021","unstructured":"Abou-Ismail MY, Rodgers GM, Bray PF, Lim MY. Acquired von Willebrand syndrome in monoclonal gammopathy - A scoping review on hemostatic management. Res Pract Thromb Haemost. 2021, 5:356-65. 10.1002\/rth2.12481","journal-title":"Res Pract Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830090403","article-title":"Pathogenesis of antibody-induced acquired von Willebrand Syndrome","volume":"9","author":"Gan TE","year":"1980","unstructured":"Gan TE, Sawers RJ, Koutts J. Pathogenesis of antibody-induced acquired von Willebrand Syndrome. Am J Hematol. 1980, 9:363-71. 10.1002\/ajh.2830090403","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell NT","year":"2021","unstructured":"Connell NT, Flood VH, Brignardello-Petersen R, et al.. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021, 5:301-25. 10.1182\/bloodadvances.2020003264","journal-title":"Blood Adv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012348","article-title":"Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease","volume":"8","author":"Merz LE","year":"2024","unstructured":"Merz LE, AbdelHameid D, Kanaan DM, Farah S, Manzo P, Connell NT. Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease. Blood Adv. 2024, 8:2244-7. 10.1182\/bloodadvances.2023012348","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-635094","article-title":"How I treat patients with inherited bleeding disorders who need anticoagulant therapy","volume":"128","author":"Martin K","year":"2016","unstructured":"Martin K, Key NS. How I treat patients with inherited bleeding disorders who need anticoagulant therapy. Blood. 2016, 128:178-84. 10.1182\/blood-2015-12-635094","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231177294","article-title":"Outcomes in patients with von Willebrand disease receiving recombinant von Willebrand factor on demand and in surgical Settings: chart review","volume":"29","author":"Sun SX","year":"2023","unstructured":"Sun SX, Lowndes S, Willock R, Jones C, Brighton S. Outcomes in patients with von Willebrand disease receiving recombinant von Willebrand factor on demand and in surgical Settings: chart review. Clin Appl Thromb Hemost. 2023, 29:10760296231177294. 10.1177\/10760296231177294","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-021-01073-0","article-title":"Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation","volume":"64","author":"Dognin N","year":"2022","unstructured":"Dognin N, Salaun E, Champagne C, et al.. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation. J Interv Card Electrophysiol. 2022, 64:497-509. 10.1007\/s10840-021-01073-0","journal-title":"J Interv Card Electrophysiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytz124","article-title":"Percutaneous left atrial appendage closure in a patient with haemophilia and atrial fibrillation: a case report","volume":"3","author":"G\u00fcray \u00dc","year":"2019","unstructured":"G\u00fcray \u00dc, Korkmaz A, G\u00fcrsoy HT, Elalm\u0131\u015f \u00d6U. Percutaneous left atrial appendage closure in a patient with haemophilia and atrial fibrillation: a case report. Eur Heart J Case Rep. 2019, 3:3. 10.1093\/ehjcr\/ytz124","journal-title":"Eur Heart J Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrcr.2019.01.014","article-title":"Combined left atrial appendage closure and ablation in a patient with hemophilia B, paroxysmal atrial fibrillation, and transient ischemic attack","volume":"5","author":"Bhatti Z","year":"2019","unstructured":"Bhatti Z, Goldbarg S. Combined left atrial appendage closure and ablation in a patient with hemophilia B, paroxysmal atrial fibrillation, and transient ischemic attack. HeartRhythm Case Rep. 2019, 5:266-8. 10.1016\/j.hrcr.2019.01.014","journal-title":"HeartRhythm Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266686-percutaneous-left-atrial-appendage-closure-in-a-patient-with-acquired-von-willebrand-disease-and-atrial-fibrillation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T07:18:24Z","timestamp":1720250304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266686-percutaneous-left-atrial-appendage-closure-in-a-patient-with-acquired-von-willebrand-disease-and-atrial-fibrillation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.63936","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,6]]}}}